2021
DOI: 10.1007/s00253-021-11151-y
|View full text |Cite
|
Sign up to set email alerts
|

Advances in monitoring and control of refolding kinetics combining PAT and modeling

Abstract: Overexpression of recombinant proteins in Escherichia coli results in misfolded and non-active protein aggregates in the cytoplasm, so-called inclusion bodies (IB). In recent years, a change in the mindset regarding IBs could be observed: IBs are no longer considered an unwanted waste product, but a valid alternative to produce a product with high yield, purity, and stability in short process times. However, solubilization of IBs and subsequent refolding is necessary to obtain a correctly folded and active pro… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
8
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 21 publications
(8 citation statements)
references
References 114 publications
(107 reference statements)
0
8
0
Order By: Relevance
“…J. 26 (6): 414-425 selected as process parameters in HIC were optimized by Box-Behnken method. Urea concentration was determined as CPP.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…J. 26 (6): 414-425 selected as process parameters in HIC were optimized by Box-Behnken method. Urea concentration was determined as CPP.…”
Section: Discussionmentioning
confidence: 99%
“…J. 26 (6): [414][415][416][417][418][419][420][421][422][423][424][425] Quantity One software (Bio-Rad). DTT concentration, incubation time, and urea concentration were selected as parameters for DoE, based on literature and previous experiences [13] .…”
Section: Optimization Of Solubilizationmentioning
confidence: 99%
See 1 more Smart Citation
“…Raman and UV-resonance Raman spectroscopy are now established biophysical tools that complement other analyses in the PAT toolbox to understand protein higher-order structure [ 113 ]. They are starting to be used in structural analysis of therapeutic proteins because they can measure in the solution phase, are compatible with isotope exchange, are non-destructive, and provide a direct measurement of protein structure.…”
Section: Applications In Biopharmaceutical Manufacturingmentioning
confidence: 99%
“…However, despite significant developments in refolding methodologies over the past two decades, issues persist and low refolding yields continue to be a concern for the manufacturers. 16,17 Hence, optimal design and operation are critical to achieve desirable yields and product quality. In this regard, machine learning (ML) is being increasingly explored as a key enabler.…”
Section: Introductionmentioning
confidence: 99%